{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:09:46Z","timestamp":1760918986439,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nucmedbio.2022.08.007","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T10:53:07Z","timestamp":1661943187000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET\/CT study in pigs"],"prefix":"10.1016","volume":"114-115","author":[{"given":"Kim","family":"Frisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Viborg","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Lajord","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Christian","family":"Gormsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aage Kristian Olsen","family":"Alstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0005","series-title":"Functional molecular imaging in hepatology","first-page":"49","article-title":"Biliary secretion","author":"Frisch","year":"2012"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0010","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr Physiol"},{"issue":"5 suppl","key":"10.1016\/j.nucmedbio.2022.08.007_bb0020","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1002\/hep.1840040803","article-title":"Chemistry and enterohepatic circulation of bile acids","volume":"4","author":"Hofmann","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0025","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.2741\/3399","article-title":"The enterohepatic circulation of bile acids in mammals: form and functions","volume":"14","author":"Hofmann","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/00498250802040584","article-title":"Bile acid transporters in health and disease","volume":"38","author":"Kosters","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0035","series-title":"Drug transporters. Handbook of experimental pharmacology","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-642-14541-4_5","article-title":"The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation","author":"Stieger","year":"2011"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0040","series-title":"Drug transporters. Handbook of experimental pharmacology","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-14541-4_4","article-title":"Role of the intestinal bile acid transporters in bile acid and drug disposition","author":"Dawson","year":"2011"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation. Physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000450987","article-title":"Roles of Ileal ASBT and OST\u03b1-OST\u03b2 in regulating bile acid signaling","volume":"35","author":"Dawson","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0060","doi-asserted-by":"crossref","unstructured":"Wagner M and Trauner M. Recent advances in understanding and managing cholestasis. F1000Res 2016;5(F1000 Faculty Rev):705. doi:10.12688\/f1000research.8012.1.","DOI":"10.12688\/f1000research.8012.1"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.dld.2010.03.015","article-title":"Bile salts and cholestasis","volume":"42","author":"Wenninger","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0070","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/apt.13570","article-title":"Review article: bile acid diarrhoa - pathogenesis, diagnosis and management","volume":"43","author":"Mottacki","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0075","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.nucmedbio.2016.07.001","article-title":"Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function","volume":"43","author":"Neyt","year":"2016","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0080","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.jorganchem.2009.06.015","article-title":"Synthesis and characterization of organometallic rhenium(\u0406) and technetium(\u0406) bile acid complexes","volume":"694","author":"Huang","year":"2009","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0085","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1021\/jm0310683","article-title":"Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging","volume":"47","author":"Anelli","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0090","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1002\/jps.24131","article-title":"Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging","volume":"103","author":"Vivian","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0095","article-title":"Using multi-fluorinated bile acids and in vivo magnetic resonance imaging to measure bile acid transport","volume":"117","author":"Felton","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0100","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1021\/acs.molpharmaceut.8b00454","article-title":"Attenuated accumulation of novel fluorine (19F)-labeled bile acid analogues in gallbladders of fibroblast growth factor-15 (FGF15)-deficient mice","volume":"15","author":"Metry","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0105","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2967\/jnumed.111.098731","article-title":"[N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET\/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs","volume":"53","author":"Frisch","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2967\/jnumed.115.161711","article-title":"Radiosynthesis of N-11C-methyl-taurine\u2013conjugated bile acids and biodistribution studies in pigs by PET\/CT","volume":"57","author":"Schacht","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nucmedbio.2014.03.016","article-title":"Synthesis and evaluation of 18F-labeled bile acid compound: a potential PET imaging agent for FXR-related diseases","volume":"41","author":"Jia","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0120","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bmcl.2015.01.008","article-title":"Novel 64Cu-radiolabeled bile acid conjugates for targeted PET imaging","volume":"25","author":"Chong","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0125","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2967\/jnumed.115.171579","article-title":"Hepatobiliary secretion kinetics of conjugated bile acids measured in pigs by 11C-cholylsarcosine PET","volume":"57","author":"S\u00f8rensen","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0130","doi-asserted-by":"crossref","first-page":"3064751","DOI":"10.1155\/2018\/3064751","article-title":"Preclinical evaluation of [18F]LCATD as a PET tracer to study drug-drug interactions caused by inhibition of hepatic transporters","volume":"2018","author":"Testa","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nucmedbio.2018.12.001","article-title":"Validation of hepatobiliary transport PET imaging in liver function assessment: evaluation of 3\u03b2-[18F]FCA in mouse models of liver disease","volume":"68-69","author":"Lombaerde","year":"2019","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhep.2017.02.023","article-title":"Hepatobiliary transport kinetics of the conjugated bile acid tracer 11C-CSar quantified in healthy humans and patients by positron emission tomography","volume":"67","author":"\u00d8rntoft","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0145","first-page":"260","article-title":"PET for bile transport kinetics","volume":"14","author":"Dickson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2020.07.028","article-title":"Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis","volume":"74","author":"Kj\u00e6rgaard","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nucmedbio.2018.04.004","article-title":"N-(4-[18F]fluorobenzyl)cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: radiosynthesis and proof-of-concept studies in rats","volume":"61","author":"Frisch","year":"2018","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0160","article-title":"Basic surgical techniques in the G\u00f6ttingen Minipig: intubation, bladder catheterization, femoral vessel catheterization, and transcardial perfusion","volume":"52","author":"Ettrup","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0165","first-page":"55","article-title":"Imaging techniques in large animals","volume":"36","author":"Alstrup","year":"2009","journal-title":"Scand J Lab Anim Sci"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2967\/jnumed.117.196261","article-title":"RADAR dose estimate report: a compendium of radiopharmaceutical dose estimates based on OLINDA\/EXM version 2.0","volume":"59","author":"Stabin","year":"2018","journal-title":"J Nucl Med"},{"issue":"3\u20134","key":"10.1016\/j.nucmedbio.2022.08.007_bb0175","first-page":"5","article-title":"Basic anatomical and physiological data for use in radiological protection. Reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89","volume":"32","year":"2002","journal-title":"Ann ICRP"},{"issue":"2\u20134","key":"10.1016\/j.nucmedbio.2022.08.007_bb0180","first-page":"1","article-title":"The 2007 recommendations of the international commission on radiological protection. ICRP publication 103","volume":"37","year":"2007","journal-title":"Ann ICRP"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0185","first-page":"795","article-title":"Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling","volume":"42","author":"Munk","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0190","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0195","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1152\/physrev.00054.2017","article-title":"Guts and gall: bile acids in regulation of intestinal epithelial function in health and disease","volume":"98","author":"Hegyi","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0200","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/mp900163d","article-title":"Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter","volume":"6","author":"Zheng","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nucmedbio.2019.07.006","article-title":"Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine","volume":"72\u201373","author":"Frisch","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0210","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003643-200203000-00037","article-title":"Propofol inhibits intestinal peristalsis in the guinea-pig ileum through action on K+ channels","volume":"19","author":"Herbert","year":"2002","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"10.1016\/j.nucmedbio.2022.08.007_bb0215","first-page":"1","article-title":"Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). ICRP publication 80","volume":"28","year":"1998","journal-title":"Ann ICRP"},{"key":"10.1016\/j.nucmedbio.2022.08.007_bb0220","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nucmedbio.2010.11.006","article-title":"Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-D-galactose from talose triflate and biodistribution in a porcine model","volume":"38","author":"Frisch","year":"2011","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805122020765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805122020765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:31:03Z","timestamp":1760848263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805122020765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":44,"alternative-id":["S0969805122020765"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.08.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"type":"print","value":"0969-8051"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET\/CT study in pigs","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}